Change in cardiovascular disease status in peritoneal dialysis patients: A 5-year single-center experience

Renal Failure

Volumn 34, Issue 1, 2012, Pages 28-34

  Mou, Shan ^a   Wang, Qin ^a   Fang, Wei ^a   Lin, Aiwu ^a   Shi, Beili ^a   Cao, Liou ^a   Zhou, Wenyan ^a   Qian, Jiaqi ^a   Ni, Zhaohui ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cardiovascular disease; Chronic renal failure; Follow up; Outcome; Peritoneal dialysis

Indexed keywords

ALBUMIN; CREATININE; TRIACYLGLYCEROL;

ADULT; ALBUMIN BLOOD LEVEL; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; CHINA; CREATININE CLEARANCE; DISEASE COURSE; FEMALE; FOLLOW UP; HEART LEFT ATRIUM; HEART LEFT ATRIUM DIMENSION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE MASS INDEX; HEART LEFT VENTRICLE SEPTAL THICKNESS; HEART VENTRICLE SEPTUM; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NUTRITIONAL STATUS; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; SURVIVAL; UREMIA;

AGED; CARDIOVASCULAR DISEASES; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 84055193315     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2011.623559     Document Type: Article

References (21)

1. Levey AS, Beto JA, Coronado BE, et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis. 1998;32:853-906. (Pubitemid 28516321)
2. Weiner DE, Tighiouart H, Stark PC, et al. Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis. 2004;44:198-206. (Pubitemid 38962547)
3. Mark JS. Cardiovascular complications in chronic kidney disease. Am J Kidney Dis. 2004;41(S5):S11-S17.
4. Parfrey PS. Cardiac disease in dialysis patients: Diagnosis, burden of disease, prognosis, risk factors and management. Nephrol Dial Transplant. 2000;15:58-68.
5. Chertow GM, Normand S-LT, Silva LR, McNeil BJ. Survival after acute myocardial infarction in patients with endstage renal disease: Results from the cooperative cardiovascular project. Am J Kidney Dis. 2000;35:1044-1051. (Pubitemid 30354405)
6. Herzog CA. Poor long-term survival of dialysis patients after acute myocardial infarction: Bad treatment or bad disease? Am J Kidney Dis. 2000;35:1217-1220. (Pubitemid 30354428)
7. Hemmelgarn BR, Ghali WA, Quan H, et al. Poor long-term survival after coronary angiography in patients with renal insufficiency. Am J Kidney Dis. 2001;37:64-72. (Pubitemid 32055020)
8. Beattie JN, Soman SS, Sandberg KR, Yee J, Borzak S, McCullough PA. Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis. 2001;37:1191-1200. (Pubitemid 32525155)
9. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med. 1998;339:799-805. (Pubitemid 28447453)
10. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(Suppl. 3):112-119.
11. Mallamaci F, Zoccali C, Tripepi G, et al. CREED investigators: The cardiovascular risk extended evaluation. Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int. 2001;59:1559-1566. (Pubitemid 32281248)
12. Adeera L, Ognjenka K, Brendan B, et al. Cardiovascular disease in patients with chronic kidney disease: Getting to the heart of the matter. Am J Kidney Dis. 2001;38:1398-1407.
13. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. Am Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358-367.
14. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1083. (Pubitemid 9091990)
15. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol. 1986;57:450-458. (Pubitemid 16119719)
16. Moon KH, Song IS, Yang WS, et al. Hypoalbuminemia as a risk factor for progressive left ventricular hypertrophy in hemodialysis patients. Am J Nephrol. 2000;20:396-401.
17. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol. 1996;7: 728-736. (Pubitemid 27466006)
18. Harty J, Venning M, Gokal R. Does CAPD guarantee adequate dialysis delivery and nutrition? Nephrol Dial Transplant. 1994;9:1721-1723.
19. Rocco MV, Yan G, Gassman J, et al. Hemodialysis Study Group. Comparison of causes of death using HEMO Study and HCFA end-stage renal disease death notification classification systems. Am J Kidney Dis. 2002;39:146-153. (Pubitemid 34062507)
20. Homma S, Hirose N, Ishida H, Ishii T, Araki G. Carotid plaque and intima-media thickness assessed by B-mode ultrasonography in subjects ranging from young adults to centenarians. Stroke. 2001;32:830-835.
21. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis. 1996;28:53-61. (Pubitemid 26231466)